Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...
Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...
Hosted on MSN
TRIM63 identified as key gene in common heart disease, unlocking potential for earlier diagnosis
An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most common hereditary heart disease worldwide. The findings, published in ...
A groundbreaking discovery from Israeli scientists is changing what doctors know about inherited heart disease. Researchers have pinpointed a gene, TRIM63, as a major contributor to hypertrophic ...
A pioneering Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most common hereditary heart disease worldwide. The findings, published ...
An analysis of two large cohort studies finds that carriers of disease-causing variants within genes for three ...
Please provide your email address to receive an email when new articles are posted on . A serum protein panel predicted risk for cardiac toxicity among childhood cancer survivors exposed to ...
COVID-19 exacerbated adverse outcomes in peripartum cardiomyopathy, increasing myocardial infarction, intensive care unit admissions, and mortality rates. Hypertrophic cardiomyopathy patients ...
Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders. This often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results